In accordance with the ACCME Standards for Integrity and Independence, it is the policy of Evolve Medical Education, LLC (Evolve) that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve Medical Education, LLC (Evolve) has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.
The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.
Faculty:
Roger A. Goldberg, MD, MBA
Partner
Bay Area Retina Associates
Walnut Creek, CA
Grant Support: AbbVie Inc., AffaMed Therapeutics, Alexion Pharmaceuticals, Inc., Annexon, Inc., Apellis Pharmaceuticals, Inc., Avirmax, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Carl Zeiss AG, Clearside Biomedical, Inc., Cognition Therapeutics, Inc., Emmetrope Ophthalmics LLC, EyePoint, Inc., Genentech, Inc., Janssen Biotech, Inc., Neurotech Pharmaceuticals, Inc., Novo Nordisk, Inc., Ocular Therapeutix, Inc., Orasis Pharmaceuticals, Regeneron Pharmaceuticals, Inc., Stealth BioTherapeutics, Unity Biotechnology, Inc.
Consultant Fees: AbbVie Inc., Alimera Sciences, Inc., Annexon, Inc., Apellis Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Carl Zeiss AG, Clearside Biomedical, Inc., Emmetrope Ophthalmics LLC, EyePoint, Inc., Genentech, Inc., Janssen Biotech, Inc., Neurotech Pharmaceuticals, Inc., Ocular Therapeutix, Inc., Orasis Pharmaceuticals, Regeneron Pharmaceuticals, Inc., Stealth BioTherapeutics, Unity Biotechnology, Inc.
Speaker Bureau: Apellis Pharmaceuticals, Inc., Genentech, Inc.
Royalties: Emmetrope Ophthalmics LLC
Katherine E. Talcott, MD
Associate Professor of Ophthalmology
Cole Eye Institute
Cleveland Clinic
Cleveland, OH
Consulting Fees: 4D Molecular Therapeutics, Inc., AbbVie Inc., Apellis Pharmaceuticals, Inc., Astellas Pharma Global Development, Inc., Bausch + Lomb Corporation, Carl Zeiss AG, EyePoint, Inc., Genentech, Inc., Harrow Health, Inc., Ocular Therapeutix, Inc., Outlook Therapeutics, Inc., Regeneron Pharmaceuticals, Inc.
Research: Carl Zeiss AG, Regeneron Pharmaceuticals, Inc
Christina Y. Weng, MD, MBA
Fellowship Program Director
Vitreoretinal Diseases & Surgery
Houston, TX
Consulting Fees: AbbVie Inc., Alcon Vision, LLC, Alimera Sciences, Inc., Apellis Pharmaceuticals, Inc., BVI Medical, Inc., Carl Zeiss AG, EyePoint, Inc., Frontera Therapeutics, Inc., Genentech, Inc., Iveric Bio, Inc., Ocular Therapeutix, Inc., Regeneron Pharmaceuticals, Inc., REGENXBIO, Inc., Stealth BioTherapeutics
Research: DRCR Retina Network
Royalties: Springer Publishers
Reviewers/Content Planners/Authors:
- Cindy Davidson has no relevant relationships to disclose.
- Erika Langsfeld, PhD, has no relevant relationships to disclose.
